CHO Pharma, Inc. (TPEX: 6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.20
-0.80 (-1.51%)
Nov 20, 2024, 11:11 AM CST
-27.09%
Market Cap 10.87B
Revenue (ttm) 1.08M
Net Income (ttm) -255.25M
Shares Out 214.01M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 122,195
Open 53.00
Previous Close 53.00
Day's Range 51.40 - 53.20
52-Week Range 51.40 - 77.50
Beta 0.07
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About CHO Pharma

CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.